Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASPIRE: An Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD

NCT05259280 is registered in ClinicalTrials.gov with Convexity Scientific Inc as lead sponsor.

NCT NCT05259280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05259280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASPIRE: An Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD
Lead sponsor
Convexity Scientific Inc
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2022
Completion date
September 8, 2022
Enrollment
153 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, chronic obstructive pulmonary disease moderate, chronic obstructive pulmonary disease severe, copd